Skip to content

Clinical trials

Phase 3 Stomach Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 3 Country / region: France Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20081
20091
20101
20122
20141
20152
20163
20173
20183
20213
20223
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Active, not recruiting4
Recruiting4
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Merck Sharp & Dohme LLC3
AstraZeneca2
Daiichi Sankyo2
Hoffmann-La Roche2
Arcus Biosciences, Inc.1
Assistance Publique - Hôpitaux de Paris1
Astellas Pharma Global Development, Inc.1
Bristol-Myers Squibb1
Centre Leon Berard1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms31
Esophageal Neoplasms5
Adenocarcinoma4
Neoplasm Metastasis3
Neoplasms3
Bile Duct Neoplasms1
Digestive System Neoplasms1
Pancreatic Neoplasms1
Recurrence1
Stomach Diseases1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.